

Cover Story
Free
Oregon flirts with—and quickly abandons—plan to deny Medicaid payment for next-generation sequencing
By Matthew Bin Han Ong
The Oregon Health Authority did a considerable amount of work to prepare a plan that would deny Medicaid coverage for next-generation sequencing tests in the state.
In Brief


Clinical Roundup


Drugs & Targets
NCI Trials


NCI Trials for September
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.
Trending Stories
- Montefiore Einstein Director Edward Chu dies of glioblastoma at 66
- Arnold D. Kaluzny, longtime adviser to the NCI and health services researcher, dies at 87
- Natalie Phelps, whose clinical trial was delayed due to RIFs, dies of colon cancer
- Oncofertility coverage mandates expand to 21 states and DC as political momentum builds
Gaps persist as patients face harrowing decisions and huge copays - Shane Jacobson talks about his to-do list for ACS
Boost research, forge closer ties with cancer centers, launch an all-out campaign for resources - GLP-1 drugs linked to dramatically lower death rates in colon cancer patients














